Streamlined hiring authority

21 U.S.C. § 379d–3

• Title: 21 — Food and Drugs
• Chapter: 9 — FEDERAL FOOD, DRUG, AND COSMETIC ACT
• Subchapter: VII
• Part: A
• Current through: Pub. L. 119-99

Text

(a) In general
In addition to any other personnel authorities under other provisions of law, the Secretary may, without regard to the provisions of title 5 governing appointments in the competitive service, appoint employees to positions in the Food and Drug Administration to perform, administer, or support activities described in subsection (b), if the Secretary determines that such appointments are needed to achieve the objectives specified in subsection (c).
(b) Activities described
The activities described in this subsection are—
(1) activities under this chapter related to the process for the review of device applications (as defined in section 379i(9) of this title); and
(2) activities under this chapter related to human generic drug activities (as defined in section 379j–41 of this title).
(c) Objectives specified
The objectives specified in this subsection are—
(1) with respect to the activities under subsection (b)(1), the goals referred to in section 379j–1(a)(1) of this title; and
(2) with respect to the activities under subsection (b)(2), the goals referred to in section 379j–43(a) of this title.
(d) Internal controls
The Secretary shall institute appropriate internal controls for appointments under this section.
(e) Sunset
The authority to appoint employees under this section shall terminate on the date that is 3 years after July 9, 2012.

History

(June 25, 1938, ch. 675, §714, as added and amended Pub. L. 112–144, title II, §208, title III, §307, July 9, 2012, 126 Stat. 1007, 1025; Pub. L. 115–52, title II, §202(b), Aug. 18, 2017, 131 Stat. 1013.)

Editorial Notes

Editorial Notes

Amendments
2017—Subsec. (b)(1). Pub. L. 115–52 substituted "379i(9)" for "379i(8)".
2012—Subsec. (b). Pub. L. 112–144, §307(1), amended subsec. (b) generally. Prior to amendment, text read as follows: "The activities described in this subsection are activities under this chapter related to the process for the review of device applications (as defined in section 379i(8) of this title)."
Subsec. (c). Pub. L. 112–144, §307(2), amended subsec. (c) generally. Prior to amendment, text read as follows: "The objectives specified in this subsection are with respect to the activities under subsection (b), the goals referred to in section 379j–1(a)(1) of this title."

Statutory Notes and Related Subsidiaries

Effective Date of 2017 Amendment
Amendment by Pub. L. 115–52 effective Oct. 1, 2017, with fees under subpart 3 of part C of this subchapter to be assessed for all submissions listed in section 379j(a)(2)(A) of this title received on or after Oct. 1, 2017, see section 209 of Pub. L. 115–52, set out as a note under section 379i of this title.

Effective Date of 2012 Amendment
Amendment by section 307 of Pub. L. 112–144 effective Oct. 1, 2012, see section 305 of Pub. L. 112–144, set out as an Effective and Termination Dates note under section 379j–41 of this title.

Effective Date
Section effective Oct. 1, 2012, see section 206 of Pub. L. 112–144, set out as an Effective Date of 2012 Amendment note under section 379i of this title.